Delivery Order SPE2DB20D2014-SPE2DB25FB74K

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D1004|SPE2DB24FF1M5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,521.84 firm-fixed-price delivery order is for 4,563,224,910 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of January 4, 2024 and was awarded on January 3, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,468.08 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets. The contract has an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Telmisartan 40 mg tablets. The award, valued at $1,293.60, is a Firm Fixed Price delivery order contract that will run through February 4, 2025. This contract appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKJWQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,972.08 firm fixed-price delivery order is for the supply of 4,568,013,514 units of the medication Telmisartan 80 mg tablets. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan 40 mg tablets. The $2,870.00 Firm Fixed Price contract is a delivery order under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,324.29 firm fixed-price delivery order is for the supply of 4,566,150 units of Telmisartan 40 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award, valued at $2,751.48, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566760931 - Telmisartan 40 mg Tablets in 30-count packages. The award has an ultimate completion date of December 19, 2024 and is structured as a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,057,318 units of the drug Telmisartan 40 mg tablets, with a ceiling value of $1,327.05. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,948.67 firm fixed-price delivery order contract is for the supply of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of December 18, 2023. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.54 firm fixed-price delivery order is for the supply of 4,567,299,271 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB74K
    Delivery Order

This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB74K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.00 firm fixed-price delivery order is for the supply of 4,568,038,617 units of the medication Telmisartan 40 mg Tablet 30s. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award is not designated as a set-aside.

Generated 7/25/25, 11:20 AM